235 related articles for article (PubMed ID: 24531649)
1. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.
Tahmasebi Mirgani M; Isacchi B; Sadeghizadeh M; Marra F; Bilia AR; Mowla SJ; Najafi F; Babaei E
Int J Nanomedicine; 2014; 9():403-17. PubMed ID: 24531649
[TBL] [Abstract][Full Text] [Related]
2. Dendrosomal curcumin nanoformulation modulate apoptosis-related genes and protein expression in hepatocarcinoma cell lines.
Montazeri M; Sadeghizadeh M; Pilehvar-Soltanahmadi Y; Zarghami F; Khodi S; Mohaghegh M; Sadeghzadeh H; Zarghami N
Int J Pharm; 2016 Jul; 509(1-2):244-254. PubMed ID: 27234697
[TBL] [Abstract][Full Text] [Related]
3. Dendrosomal curcumin significantly suppresses cancer cell proliferation in vitro and in vivo.
Babaei E; Sadeghizadeh M; Hassan ZM; Feizi MA; Najafi F; Hashemi SM
Int Immunopharmacol; 2012 Jan; 12(1):226-34. PubMed ID: 22155627
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and Apoptotic Effect of Dendrosomal Curcumin Nanoformulation in P53 Mutant and Wide-Type Cancer Cell Lines.
Montazeri M; Pilehvar-Soltanahmadi Y; Mohaghegh M; Panahi A; Khodi S; Zarghami N; Sadeghizadeh M
Anticancer Agents Med Chem; 2017; 17(5):662-673. PubMed ID: 27604683
[TBL] [Abstract][Full Text] [Related]
5. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
6. Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells.
Keshavarz R; Bakhshinejad B; Babashah S; Baghi N; Sadeghizadeh M
Iran J Basic Med Sci; 2016 Dec; 19(12):1353-1362. PubMed ID: 28096969
[TBL] [Abstract][Full Text] [Related]
7. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
8. MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression.
Niu CS; Yang Y; Cheng CD
Int J Oncol; 2013 May; 42(5):1533-40. PubMed ID: 23467648
[TBL] [Abstract][Full Text] [Related]
9. Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment.
Shiri S; Alizadeh AM; Baradaran B; Farhanghi B; Shanehbandi D; Khodayari S; Khodayari H; Tavassoli A
Asian Pac J Cancer Prev; 2015; 16(9):3917-22. PubMed ID: 25987060
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of lncRNA, GAS5 decreases chemotherapeutic effect of dendrosomal curcumin (DNC) in breast cancer cells.
Esmatabadi MJD; Motamedrad M; Sadeghizadeh M
Phytomedicine; 2018 Mar; 42():56-65. PubMed ID: 29655698
[TBL] [Abstract][Full Text] [Related]
11. Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through Down-regulation of Claudin1, Zeb1 and Hef1-1 gene expression.
Dehghan Esmatabadi MJ; Farhangi B; Safari Z; Kazerooni H; Shirzad H; Zolghadr F; Sadeghizadeh M
Asian Pac J Cancer Prev; 2015; 16(6):2473-81. PubMed ID: 25824783
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells.
Kumar A; Ahuja A; Ali J; Baboota S
Drug Deliv; 2016; 23(1):214-29. PubMed ID: 24825490
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death.
Liu L; Lian J; Zhang H; Tian H; Liang M; Yin M; Sun F
J Cell Physiol; 2013 Dec; 228(12):2294-304. PubMed ID: 23625774
[TBL] [Abstract][Full Text] [Related]
14. Comparative SRY incorporation on the regulatory regions of pluripotency/differentiation genes in human embryonic carcinoma cells after retinoic acid induction.
Kakhki SA; Shahhoseini M; Salekdeh GH
Mol Cell Biochem; 2013 Apr; 376(1-2):145-50. PubMed ID: 23361361
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin.
Chamani F; Sadeghizadeh M; Masoumi M; Babashah S
Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229
[TBL] [Abstract][Full Text] [Related]
16. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
[TBL] [Abstract][Full Text] [Related]
17. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
20. Curcumin nanomedicine: a road to cancer therapeutics.
Yallapu MM; Jaggi M; Chauhan SC
Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
